Impact of TP53 mutation status on systemic treatment outcome in ALK-rearranged non-small-cell lung cancer
Kron, A., Alidousty, C., Scheffler, M., Merkelbach-Bruse, S., Seidel, D., Riedel, R., Ihle, M. A., Michels, S., Nogova, L., Fassunke, J., Heydt, C., Kron, F., Ueckeroth, F., Serke, M., Krüger, S., Grohe, C., Koschel, D., Benedikter, J., Kaminsky, B., Schaaf, B., Braess, J., Sebastian, M., Kambartel, K.-O., Thomas, R., Zander, T., Schultheis, A. M., Büttner, R. and Wolf, J. (2018) Impact of TP53 mutation status on systemic treatment outcome in ALK-rearranged non-small-cell lung cancer. Annals of Oncology 29 (10), pp. 2068-2075.Date of publication of this fulltext: 28 Jul 2021 17:01
Article
Alternative links to fulltext
Involved Institutions
Details
| Item type | Article | ||||
| Journal or Publication Title | Annals of Oncology | ||||
| Volume: | 29 | ||||
|---|---|---|---|---|---|
| Number of Issue or Book Chapter: | 10 | ||||
| Page Range: | pp. 2068-2075 | ||||
| Date | 2018 | ||||
| Institutions | UNSPECIFIED | ||||
| Identification Number |
| ||||
| Dewey Decimal Classification | UNSPECIFIED | ||||
| Status | Published | ||||
| Refereed | Yes, this version has been refereed | ||||
| Created at the University of Regensburg | Yes | ||||
| Item ID | 46698 |
Export bibliographical data
Owner only: item control page
Altmetric
Altmetric